Press releases NEW HOPE FOR MALARIA TREATMENT AS TANZANIAN SCIENTISTS LEAD GROUNDBREAKING CLINICAL TRIAL Development of the Candidate Tuberculosis Vaccine H56:IC31 Ended Based on Early Data from the Prevention of Recurrence (POR) TB Consortium
